| 000 | 01534 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250511202757.0 | ||
| 264 | 0 | _c19920114 | |
| 008 | 199201s 0 0 eng d | ||
| 022 | _a0390-6078 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPileri, S | |
| 245 | 0 | 0 |
_aImmunohistochemistry of malignant lymphomas. Advantages and limitations of the new monoclonal antibodies working in paraffin sections. _h[electronic resource] |
| 260 |
_bHaematologica _c |
||
| 300 |
_a226-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 |
_aAntibodies, Neoplasm _ximmunology |
| 650 | 0 | 4 | _aAntibody Specificity |
| 650 | 0 | 4 |
_aAntigens, Differentiation _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 | _aCross Reactions |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunohistochemistry _xmethods |
| 650 | 0 | 4 |
_aImmunophenotyping _xmethods |
| 650 | 0 | 4 |
_aLymphoma _xclassification |
| 650 | 0 | 4 |
_aNeoplasm Proteins _ximmunology |
| 650 | 0 | 4 |
_aNeoplastic Stem Cells _ximmunology |
| 650 | 0 | 4 | _aParaffin |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _ximmunology |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-bcl-2 |
| 700 | 1 | _aFalini, B | |
| 700 | 1 | _aSabattini, E | |
| 700 | 1 | _aBigerna, B | |
| 700 | 1 | _aGherlinzoni, F | |
| 700 | 1 | _aTazzari, P L | |
| 773 | 0 |
_tHaematologica _gvol. 76 _gno. 3 _gp. 226-34 |
|
| 999 |
_c1750005 _d1750005 |
||